About
CNM leverages the wealth of discoveries across the Emory ecosystem to populate the early stages of a drug discovery and development pipeline
CNM: A holistic approach to drug discovery at Emory
Competitive RFP
The CNM competitive RFP process (launching Fall 2024) aims to identify, vet, and select promising, early-stage drug discovery projects from Emory faculty for support through the CNM therapeutic discovery pipeline. The application and selection process, which includes intellectual property and competitive landscape analyses, provides useful feedback to faculty as they shape and grow their drug discovery goals. Selected projects will receive tailored funds and access to enabling resources to advance their project to the next stage.
Click here to learn more
Project Guidance + Consultation
CNM serves as a "hub" for Emory investigators focused on drug discovery and development. To complement our competitive RFP process and enable more groups throughout the Emory ecosystem, we also provide a spectrum of support to advance drug discovery projects, including initial project discussions and evaluation, internal reviews for resources and connection points, facilitated interactions with experts and internal supports, soft handoffs to collaborators and/or enabling groups, and continued oversight to ensure timely project progression.
Click here to schedule a project consultation/discussion
Programming + Training
CNM believes that a therapeutic discovery pipeline is only as good as the ecosystem from which it sources projects. To grow and foster the therapeutic innovation community at Emory, CNM provides tailored programming and training opportunities for drug discovery scientists, including: seminars and symposia crafted to educate and inspire, networking events to identify collaborators and enabling groups, research development tailored to stimulate/support drug discovery, and training opportunities for graduate students and postdocs.
Click here to learn more
CNM Leadership
Haian Fu, PhD
Co-Director, Emory Center for New Medicines
Professor and Chair, Department of Pharmacology and Chemical Biology
Winship Partner in Research Endowed Chair, Winship Cancer Institute
Leader, Winship Cancer Institute, Discovery & Developmental Therapeutics Program
Associate Dean for Innovation and International Strategies
Director, Emory Chemical Biology Discovery Center

Dennis Liotta, PhD
Co-Director, Emory Center for New Medicines
Samuel Candler Dobbs Professor of Chemistry
Professor, Department of Pharmacology and Chemical Biology
Chair, Advisory Committee of DRug Innovation Ventures at Emory (DRIVE) and Emory Institute for Drug Development (EIDD)

Callie Wigington, PhD
Program Director, Center for New Medicines
PhD in Biochemistry, Cell, and Developmental Biology from Emory University
Postdoctoral Fellowship in Biology at Stanford University

CNM Internal Advisors
Ravi Thadhani, MD
- Executive Vice President of Health Affairs, Emory University
Sandra Wong, MD
- Dean, Emory University School of Medicine
Guido Silvestri, MD
Executive Associate Dean for Research Strategy, Emory University School of Medicine
Suresh Ramalingam, MD
- Executive Director, Winship Cancer Institute at Emory University
Allan Levey, MD, PhD
- Founding Director, Goizueta Institute @Emory Brain Health
Huw Davies, PhD
- Asa Griggs Candler Professor of Chemistry, Emory University
George Painter, PhD
- CEO of Drug Innovation Ventures at Emory (DRIVE) and Director of the Emory Institute for Drug Development (EIDD)
Todd Sherer, PhD
- Executive Director, Emory Office of Technology Transfer